PADCEV KEYTRUDA Urothelial Cancer: Advancements...

By Staff Writer

August 13, 2025

A newly published Pfizer press release presents clinical trial results indicating that the combination therapy PADCEV™ (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) significantly improves overall survival in patients with previously unt...
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...
Donanemab Alzheimer’s Approval: A New Era in Treatment
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
AI in Real-World Evidence: Insights from Mitch Higashi
NICE’s 2025 Guidance on Obesity Management Support
Enhancing Patient Involvement in EU JCAs
Mental Health Policy Integration: A Cross-Sector Imperative for Well-being an...
Novartis Gains Approval for Groundbreaking Malaria Treatment for Infants
ViiV Healthcare Licensing: Expanding Access to Long-Acting HIV Treatment in L...
FDA Approval of ANZUPGO: A New Chronic Hand Eczema Treatment
Urgent Call to Action for EU Clinical Trials Strategy